BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15257911)

  • 1. [Diagnosis of osseous metastases of malignant tumors by bone scanning combined with bone alkaline phosphatase detection].
    Fan YX; Luo RC; Li GP; Huang K
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Jul; 24(7):812-4. PubMed ID: 15257911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of therapeutic effects of strontium-89 on osseous metastases of prostate cancer by bone scanning and B-AKP measurement].
    Fan Y; Luo R; Li G; Huang K
    Zhonghua Nan Ke Xue; 2004 Mar; 10(3):178-81. PubMed ID: 15080060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of bone-specific alkaline phosphatase for bone metastases detection in prostate cancer].
    Rasch-Isla Muñoz A; Cataño Cataño JG
    Arch Esp Urol; 2004 Sep; 57(7):693-8. PubMed ID: 15536950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum bone-specific alkaline phosphatase as a biomarker for osseous metastases in patients with malignant carcinomas: a systematic review and meta-analysis.
    Du WX; Duan SF; Chen JJ; Huang JF; Yin LM; Tong PJ
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C140-3. PubMed ID: 25450272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of whole-body bone scanning and clinical factors in detecting bone metastases in patients with non-small cell lung cancer.
    Erturan S; Yaman M; Aydin G; Uzel I; Müsellim B; Kaynak K
    Chest; 2005 Feb; 127(2):449-54. PubMed ID: 15705981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of circulating Dickkopf-1 with a new two-site immunoassay in healthy subjects and women with breast cancer and bone metastases.
    Voorzanger-Rousselot N; Journe F; Doriath V; Body JJ; Garnero P
    Calcif Tissue Int; 2009 May; 84(5):348-54. PubMed ID: 19252761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radionuclide bone scan, radiographic bone survey, and alkaline phosphatase: studies of limited value in asymptomatic patients with ovarian carcinoma.
    Mettler FA; Christie JH; Crow NE; Garcia JF; Wicks JD; Bartow SA
    Cancer; 1982 Oct; 50(8):1483-5. PubMed ID: 6288213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expressiveness of Bone Markers in Breast Cancer with Bone Metastases.
    Zulauf N; Brüggmann D; Groneberg D; Oremek GM
    Oncology; 2019; 97(4):236-244. PubMed ID: 31412345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of bone alkaline phosphatase and prostate specific antigen in the diagnosis of bone metastasis in prostate cancer.
    Lorente JA; Morote J; Raventos C; Encabo G; Valenzuela H
    J Urol; 1996 Apr; 155(4):1348-51. PubMed ID: 8632571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of bone scans in assessing malignant melanoma in patients with stage III disease.
    Devereux D; Johnston G; Blei L; Head G; Makuch R; Burt M
    Surg Gynecol Obstet; 1980 Jul; 151(1):45-8. PubMed ID: 7384983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
    Heusner T; Gölitz P; Hamami M; Eberhardt W; Esser S; Forsting M; Bockisch A; Antoch G
    Eur J Radiol; 2011 Jun; 78(3):430-5. PubMed ID: 19945240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer--A Prospective Double-Blinded Study at two Hospital Centers].
    Ohlmann-Knafo S; Kirschbaum M; Fenzl G; Pickuth D
    Rofo; 2009 Mar; 181(3):255-63. PubMed ID: 19229791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma acid and alkaline phosphatase in patients with breast cancer.
    Nguyen M; Bonneterre J; Hecquet B; Desoize B; Demaille A
    Anticancer Res; 1991; 11(2):831-3. PubMed ID: 2064338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic imaging of bone metastases].
    Scutellari PN; Addonisio G; Righi R; Giganti M
    Radiol Med; 2000 Dec; 100(6):429-35. PubMed ID: 11307503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone and total alkaline phosphatase for screening skeletal metastasis in patients with solid tumours.
    Schindler F; Lajolo PP; Pinczowski H; Fonseca FL; Barbieri A; Massonetto LH; Katto FT; Del Giglio A
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):152-6. PubMed ID: 18302652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship of serum prostate-specific antigen and alkaline phosphatase levels with bone metastases in patients with prostate cancer].
    Wang ZL; Wang XF
    Zhonghua Nan Ke Xue; 2005 Nov; 11(11):825-7. PubMed ID: 16333960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum ostase in the follow-up of breast cancer patients.
    Marchei P; Santini D; Bianco V; Chiodini S; Reale MG; Simeoni F; Marchei GG; Vecchione A
    Anticancer Res; 1995; 15(5B):2217-22. PubMed ID: 8572628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone alkaline phosphatase besides intact parathyroid hormone in hemodialysis patients--any advantage?
    Jorge C; Gil C; Possante M; Silva E; Andrade R; Santos N; Cruz A; Teixeira R; Ferreira A
    Nephron Clin Pract; 2005; 101(3):c122-7. PubMed ID: 16015001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
    Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
    Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT.
    Even-Sapir E; Metser U; Flusser G; Zuriel L; Kollender Y; Lerman H; Lievshitz G; Ron I; Mishani E
    J Nucl Med; 2004 Feb; 45(2):272-8. PubMed ID: 14960647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.